pharma
Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free
February 5, 2019Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing
Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify …
Alexander Hardy returns to Genentech as new CEO
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Positive CHMP recommendation for Sanofi’s atherosclerotic CVD drug Praluent
February 4, 2019Sales and Marketing Europe, atherosclerotic cardiovascular disease, cvd, pharma, praluent
It has been announced that Sanofi’s Praluent (alirocumab) has been awarded a positive recommendation from the European Medicines Agency’s Committee …
FDA knocks back Alkermes’ opioid-based depression therapy over lack of evidence
February 4, 2019Sales and Marketing Alkermes, FDA, major depressive disorder, pharma, rejection
Alkermes experimental opioid-based depression therapy ALKS 5461 has been rejected by the FDA, it has emerged, in the adjunctive treatment …
Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx
February 1, 2019Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma
In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …
Top Ten most popular articles on Pharmafile.com this week!
February 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10
Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma
February 1, 2019Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma
NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …
Repurposed drugs: The Supreme Court deals a blow to patentees
January 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma
Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Janssen’s Erleada meets primary endpoints in ongoing trial into metastatic castration-sensitive prostate cancer
January 31, 2019Research and Development Cancer, Erleada, Janssen, pharma, prostate cancer
Janssen has revealed that its androgen receptor (AR) inhibitor Erleada (apalutamide), in combination with androgen deprivation therapy (ADT), has been …
Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler
January 31, 2019Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma
Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …
Read Pharmafocus January/February 2019 edition online now!
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines
We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
Roche pulls plug on Alzheimer’s drug after Phase 3 failure
January 30, 2019Research and Development AC Immune, Alzheimer's, Roche, crenezumab, pharma
Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …
Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia
January 29, 2019Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma
It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …
Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance
January 29, 2019Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma
UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …
Alexander Hardy returns to Genentech as new CEO
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
